The Substrate Specificity of Sirtuins

Annual Review of Biochemistry

Volumn 85, Issue , 2016, Pages 405-429

  Bheda, Poonam ^a,b   Jing, Hui ^c   Wolberger, Cynthia ^d   Lin, Hening ^c  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Department of Obstetrics Gynecology   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADP ribosylation; Deacylation; Myristoylation; Palmitoylation; Succinylation

Indexed keywords

FUNCTIONAL GROUP; GLUTARYL GROUP; LYSINE; MALONYL GROUP; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDE; PROPIONYL GROUP; SIRTUIN; SIRTUIN 5; SUCCINYL GROUP; UNCLASSIFIED DRUG; HISTONE; MYRISTIC ACID; SUCCINIC ACID;

ACYLATION; ADENOSINE DIPHOSPHATE RIBOSYLATION; AMINO ACID SEQUENCE; ARTICLE; DEACYLATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CHEMISTRY; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; IN VIVO STUDY; LIPOYLATION; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HYDROLYSIS; KINETICS; METABOLISM; MOLECULAR MODEL; PLASMODIUM FALCIPARUM; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; THERMOTOGA MARITIMA;

ACYLATION; GENE EXPRESSION; HISTONES; HUMANS; HYDROLYSIS; KINETICS; LIPOYLATION; MODELS, MOLECULAR; MYRISTIC ACID; NAD; PLASMODIUM FALCIPARUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, SECONDARY; SIRTUINS; SUBSTRATE SPECIFICITY; SUCCINIC ACID; THERMOTOGA MARITIMA;

EID: 84974727339     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-060815-014537     Document Type: Article

References (151)

1. Frye RA. 2000. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273:793-98
2. Bosch-Presegue L, Vaquero A. 2015. Sirtuin-dependent epigenetic regulation in the maintenance of genome integrity. FEBS J. 282:1745-67
3. Masri S, Sassone-Corsi P. 2014. Sirtuins and the circadian clock: bridging chromatin and metabolism. Sci. Signal. 7:re6
4. Choi JE, Mostoslavsky R. 2014. Sirtuins, metabolism, and DNA repair. Curr. Opin. Genet. Dev. 26:24-32
5. Ng F, Tang BL. 2013. Sirtuins' modulation of autophagy. J. Cell. Physiol. 228:2262-70
6. Houtkooper RH, Pirinen E, Auwerx J. 2012. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13:225-38
7. Guarente L. 2011. Sirtuins, aging, and metabolism. Cold Spring Harb. Symp. Quant. Biol. 76:81-90
8. Haigis MC, Sinclair DA. 2010. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. Mech. Dis. 5:253-95
9. Imai S, ArmstrongCM, Kaeberlein M, Guarente L. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800
10. Tanner KG, Landry J, Sternglanz R, Denu JM. 2000. Silent information regulator 2 family of NADdependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. PNAS 97:14178-82
11. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, et al. 2000. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. PNAS 97:5807-11
12. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, et al. 2004. Modulation of NF-?B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369-80
13. Luo J, Nikolaev AY, Imai S-I, Chen D, Su F, et al. 2001. Negative control of p53 by Sir2? promotes cell survival under stress. Cell 107:137-48
14. Vaziri H, Dessain SK, Eaton EN, Imai S-I, Frye RA, et al. 2001. hSIR2SIRT1 functions as an NADdependent p53 deacetylasE. Cell 107:149-59
15. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1?and SIRT1. Nature 434:113-18
16. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-15
17. Hu J, Jing H, Lin H. 2014. Sirtuin inhibitors as anticancer agents. Future Med. Chem. 6:945-66
18. Chen Y, Sprung R, Tang Y, Ball H, Sangras B, et al. 2007. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteom. 6:812-19
19. Metoyer CF, Pruitt K. 2008. The role of sirtuin proteins in obesity. Pathophysiology 15:103-8
20. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. 2008. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177:861-70
21. Jiang H, Khan S, Wang Y, Charron G, He B, et al. 2013. SIRT6 regulates TNF-? secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496:110-13
22. Eskandarian HA, Impens F, Nahori MA, Soubigou G, Coppee JY, et al. 2013. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 341:1238858
23. Pinzone MR, Cacopardo B, Condorelli F, Di Rosa M, Nunnari G. 2013. Sirtuin-1 and HIV-1: An overview. Curr. Drug Targets 14:648-52
24. Chakraborty C, Doss CG. 2013. Sirtuins family-recent development as a drug target for aging, metabolism, and age related diseases. Curr. Drug Targets 14:666-75
25. Brachmann CB, Sherman JM, Devine SE, Cameron EE, Pillus L, Boeke JD. 1995. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 9:2888-902
26. Derbyshire MK, Weinstock KG, Strathern JN. 1996. HST1, a new member of the SIR2 family of genes. Yeast 12:631-40
27. Du J, Zhou Y, Su X, Yu J, Khan S, et al. 2011. Sirt5 is an NAD-dependent protein lysine demalonylase and desuccinylase. Science 334:806-9
28. Zhu AY, Zhou Y, Khan S, Deitsch KW, Hao Q, Lin H. 2012. Plasmodium falciparum Sir2A preferentially hydrolyzes medium and long chain fatty acyl lysine. ACS Chem. Biol. 7:155-59
29. Feldman JL, Baeza J, Denu JM. 2013. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 288:31350-56
30. He B, Hu J, Zhang X, Lin H. 2014. Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors. Org. Biomol. Chem. 12:7498-502
31. Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, et al. 2011. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteom. 10(12):M111. 012658
32. Tan M, Peng C, Anderson KA, Chhoy P, Xie Z, et al. 2014. Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab. 19:605-17
33. Tan M, Luo H, Lee S, Jin F, Yang Jeong S, et al. 2011. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146:1016-28
34. Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y. 2011. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7:58-63
35. Park J, Chen Y, Tishkoff DX, Peng C, Tan M, et al. 2013. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 50:919-30
36. Colak G, Xie Z, Zhu AY, Dai L, Lu Z, et al. 2013. Identification of lysine succinylation substrates and the succinylation regulatory enzyme CobB in Escherichia coli. Mol. Cell. Proteom. 12:3509-20
37. Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, et al. 2013. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18:920-33
38. Sauve AA, Wolberger C, Schramm VL, Boeke JD. 2006. The biochemistry of sirtuins. Annu. Rev. Biochem. 75:435-65
39. Yuan H, Marmorstein R. 2012. Structural basis for sirtuin activity and inhibition. J. Biol. Chem. 287:42428-35
40. Marmorstein R. 2001. Structure of histone deacetylases: insights into substrate recognition and catalysis. Structure 9:1127-33
41. Shore D, Squire M, Nasmyth KA. 1984. Characterization of two genes required for the position-effect control of yeast mating-type genes. EMBO J. 3:2817-23
42. Tsang AW, Escalante-Semerena JC. 1998. CobB, a new member of the SIR2 family of eucaryotic regulatory proteins, is required to compensate for the lack of nicotinate mononucleotide:5, 6-dimethylbenzimidazole phosphoribosyltransferase activity in cobT mutants during cobalamin biosynthesis in Salmonella typhimurium LT2. J. Biol. Chem. 273:31788-94
43. Frye RA. 1999. Characterization of five human cDNAs with homology to the yeast Sir2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260:273-79
44. Tanny JC, Dowd GJ, Huang J, Hilz H, Moazed D. 1999. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 99:735-45
45. Sauve AA, Celic I, Avalos J, Deng H, Boeke JD, Schramm VL. 2001. Chemistry of gene silencing: The mechanism of NAD+-dependent deacetylation reactions. Biochemistry 40:15456-63
46. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, et al. 2006. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic?cells. Cell 126:941-54
47. Mao Z, Hine C, Tian X, Van Meter M, Au M, et al. 2011. SIRT6 promotes DNA repair under stress by activating PARP1. Science 332:1443-46
48. Liszt G, Ford E, Kurtev M, Guarente L. 2005. Mouse Sir2 homolog SIRT6 is a nuclear ADPribosyltransferase. J. Biol. Chem. 280:21313-20
49. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. 2005. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 16:4623-35
50. Kowieski TM, Lee S, Denu JM. 2008. Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2. J. Biol. Chem. 283:5317-26
51. Du J, Jiang H, Lin H. 2009. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogs and 32P-NAD. Biochemistry 48:2878-90
52. Lin H, Su X, He B. 2012. Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem. Biol. 7:947-60
53. Newman JC, He W, Verdin E. 2012. Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J. Biol. Chem. 287:42436-43
54. Smith BC, Denu JM. 2006. Sir2 protein deacetylases: Evidence for chemical intermediates and functions of a conserved histidine. Biochemistry 45:272-82
55. Garrity J, Gardner JG, Hawse W, Wolberger C, Escalante-Semerena JC. 2007. N-lysine propionylation controls the activity of propionyl-CoA synthetase. J. Biol. Chem. 282:30239-45
56. Xie Z, Dai J, Dai L, Tan M, Cheng Z, et al. 2012. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteom. 11:100-7
57. Sauve AA, Schramm VL. 2003. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry 42:9249-56
58. Jackson MD, Denu JM. 2002. Structural identification of 2-and 3-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of NAD+-dependent histone/protein deacetylases. J. Biol. Chem. 277:18535-44
59. Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM. 2003. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J. Biol. Chem. 278:50985-98
60. Smith BC, Denu JM. 2007. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide. Biochemistry 46:14478-86
61. Hawse WF, Hoff KG, Fatkins DG, Daines A, Zubkova OV, et al. 2008. Structural insights into intermediate steps in the Sir2 deacetylation reaction. Structure 16:1368-77
62. Hoff KG, Avalos JL, Sens K, Wolberger C. 2006. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide. Structure 14:1231-40
63. Zhao K, Chai X, MarmorsteinR. 2003. Structure of the yeastHst2 protein deacetylase in ternary complex with 2-O-acetyl ADP ribose and histone peptide. Structure 11:1403-11
64. Bedalov A, Gatbonton T, Irvine WP, Gottschling DE, Simon JA. 2001. Identification of a small molecule inhibitor of Sir2p. PNAS 98:15113-18
65. French JB, Cen Y, Sauve AA. 2008. Plasmodium falciparum Sir2 is anNAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase. Biochemistry 47:10227-39
66. Jiang T, Zhou X, Taghizadeh K, Dong M, Dedon PC. 2007. N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage. PNAS 104:60-65
67. Cen Y, Sauve AA. 2010. Transition state of ADP-ribosylation of acetyllysine catalyzed by Archaeoglobus fulgidus Sir2 determined by kinetic isotope effects and computational approaches. J. Am. Chem. Soc. 132:12286-98
68. Sanders BD, Jackson B, Marmorstein R. 2010. Structural basis for sirtuin function: what we know and what we don't. Biochim. Biophys. Acta 1804:1604-16
69. Rossmann MG, Argos P. 1978. The taxonomy of binding sites in proteins. Mol. Cell. Biochem. 21:161-82
70. Avalos JL, Celic I, Muhammad S, Cosgrove MS, Boeke JD, Wolberger C. 2002. Structure of a Sir2 enzyme bound to an acetylated p53 peptide. Mol. Cell 10:523-35
71. Min J, Landry J, Sternglanz R, Xu R-M. 2001. Crystal structure of a SIR2 homolog-NAD complex. Cell 105:269-79
72. Bheda P, Wang JT, Escalante-Semerena JC, Wolberger C. 2011. Structure of Sir2Tm bound to a propionylated peptide. Protein Sci. 20:131-39
73. Cosgrove MS, Bever K, Avalos JL, Muhammad S, Zhang X, Wolberger C. 2006. The structural basis of sirtuin substrate affinity. Biochemistry 45:7511-21
74. Avalos J, Boeke JD, Wolberger C. 2004. Structural basis for the mechanism and regulation of Sir2 enzymes. Mol. Cell 13:639-48
75. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, et al. 2003. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12:51-62
76. Zhao K, Chai X, Marmorstein R. 2004. Structure and substrate binding properties of cobB, a Sir2 homolog protein deacetylase from Escherichia coli. J. Mol. Biol. 337:731-41
77. Schuetz A, Min J, Antoshenko T, Wang C-L, Allali-Hassani A, et al. 2007. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 15:377-89
78. Borra MT, Langer MR, Slama JT, Denu JM. 2004. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. Biochemistry 43:9877-87
79. Zhao K, Harshaw R, Chai X, Marmorstein R. 2004. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD+-dependent Sir2 histone/protein deacetylases. PNAS USA 101:8563-68
80. Zhou Y, Zhang H, He B, Du J, Lin H, et al. 2012. The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5). J. Biol. Chem. 287:28307-14
81. Bell SD, Botting CH, Wardleworth BN, Jackson SP, White MF. 2002. The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation. Science 296:148-51
82. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Cohen H, et al. 2002. Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J. Biol. Chem. 277:18881-90
83. SchmidtMT, Smith BC, JacksonMD, Denu JM. 2004. Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulation. J. Biol. Chem. 279:40122-29
84. Denu JM. 2003. Linking chromatin function with metabolic networks: Sir2 family of NAD+-dependent deacetylases. Trends Biochem. Sci. 28:41-48
85. Avalos JL, Bever KM, Wolberger C. 2005. Mechanism of sirtuin inhibition by nicotinamide: Altering the NAD+ cosubstrate specificity of a Sir2 enzyme. Mol. Cell 17:855-68
86. Sauve AA, Moir RD, Schramm VL, Willis IM. 2005. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol. Cell 17:595-601
87. Grunstein M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349-52
88. Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC. 2002. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science 298:2390-92
89. Smith BC, Denu JM. 2007. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases. J. Biol. Chem. 282:37256-65
90. Zhang K, Chen Y, Zhang Z, Zhao Y. 2008. Identification and verification of lysine propionylation and butyrylation in yeast core histones using PTMap software. J. Proteome Res. 8:900-6
91. Cheng Z, Tang Y, Chen Y, Kim S, Liu H, et al. 2009. Molecular characterization of propionyllysines in non-histone proteins. Mol. Cell. Proteom. 8:45-52
92. Liu B, Lin Y, Darwanto A, Song X, Xu G, Zhang K. 2009. Identification and characterization of propionylation at histone H3 lysine 23 in mammalian cells. J. Biol. Chem. 284:32288-95
93. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CFW, Steegborn C. 2008. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 382:790-801
94. Nakagawa T, Lomb DJ, Haigis MC, Guarente L. 2009. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cyclE. Cell 137:560-70
95. Nishida Y, Rardin MJ, Carrico C, He W, Sahu AK, et al. 2015. SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol. Cell 59:321-32
96. Ringel AE, Roman C, Wolberger C. 2014. Alternate deacylating specificities of the archaeal sirtuins Sir2Af1 and Sir2Af2. Protein Sci. 23:1686-97
97. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, et al. 2008. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452:492-96
98. Michishita E, McCord RA, Boxer LD, Barber MF, Hong T, et al. 2009. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8:2664-66
99. Yang B, Zwaans BMM, Eckersdorff M, Lombard DB. 2009. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 8:2662-63
100. Kaidi A, Weinert BT, Choudhary C, Jackson SP. 2010. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329:1348-53
101. Schwer B, Schumacher B, Lombard DB, Xiao C, Kurtev MV, et al. 2010. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. PNAS 107:21790-94
102. Wajant H, Pfizenmaier K, Scheurich P. 2003. Tumor necrosis factor signaling. Cell Death. Differ. 10:45-65
103. Stevenson FT, Bursten SL, Locksley RM, Lovett DH. 1992. Myristyl acylation of the tumor necrosis factor ?precursor on specific lysine residues. J. Exp. Med. 176:1053-62
104. Van Gool F, Galli M, Gueydan C, Kruys V, Prevot P-P, et al. 2009. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat. Med. 15:206-10
105. Teng Y-B, Jing H, Aramsangtienchai P, He B, Khan S, et al. 2015. Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies. Sci. Rep. 5:8529
106. Feldman JL, Dittenhafer-Reed KE, Kudo N, Thelen JN, Ito A, et al. 2015. Kinetic and structural basis for acyl-group selectivity and NAD+ dependence in sirtuin-catalyzed deacylation. Biochemistry 54:3037-50
107. Mathias RA, Greco TM, Oberstein A, Budayeva HG, Chakrabarti R, et al. 2014. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell 159:1615-25
108. Bao X, Wang Y, Li X, Li XM, Liu Z, et al. 2014. Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach. ELife 3:e02999
109. Wísniewski JR, Zougman A, Mann M. 2008. N formylation of lysine is a widespread post-translational modification of nuclear proteins occurring at residues involved in regulation of chromatin function. Nucl. Acids Res. 36:570-77
110. Moellering RE, Cravatt BF. 2013. Functional lysine modification by an intrinsically reactive primary glycolytic metabolite. Science 341:549-53
111. Blander G, Olejnik J, Krzymanska-Olejnik E, McDonagh T, Haigis M, et al. 2005. SIRT1 shows no substrate specificity in vitro. J. Biol. Chem. 280:9780-85
112. Rauh D, Fischer F, Gertz M, Lakshminarasimhan M, Bergbrede T, et al. 2013. An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms. Nat. Commun. 4:2327
113. Garske AL, Denu JM. 2006. SIRT1 top 40 hits: use of one-bead, one-compound acetyl-peptide libraries and quantum dots to probe deacetylase specificity. Biochemistry 45:94-101
114. AbouElfetouh A, Kuhn ML, Hu LI, Scholle MD, Sorensen DJ, et al. 2015. The E. Coli sirtuin CobB shows no preference for enzymatic and nonenzymatic lysine acetylation substrate sites. MicrobiologyOpen 4:66-83
115. Smith BC, Settles B, Hallows WC, CravenMW, Denu JM. 2011. SIRT3 substrate specificity determined by peptide arrays and machine learning. ACS Chem. Biol. 6:146-57
116. Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, et al. 2013. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49:186-99
117. Khan AN, Lewis PN. 2005. Unstructured conformations are a substrate requirement for the Sir2 family of NAD-dependent protein deacetylases. J. Biol. Chem. 280:36073-78
118. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, et al. 2010. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121-25
119. Bharathi SS, Zhang Y, Mohsen AW, Uppala R, Balasubramani M, et al. 2013. Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site. J. Biol. Chem. 288:33837-47
120. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E. 2006. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. PNAS 103:10224-29
121. Kawahara TLA, Michishita E, Adler AS, Damian M, Berber E, et al. 2009. SIRT6 links histone H3 lysine 9 deacetylation to NF-?B-dependent gene expression and organismal life span. Cell 136:62-74
122. Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, et al. 2010. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1?. Cell 140:280-93
123. Sebastián C, Zwaans BMM, Silberman DM, Gymrek M, Goren A, et al. 2012. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151:1185-99
124. Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, et al. 2012. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487:114-18
125. Merrick CJ, Duraisingh MT. 2007. Plasmodium falciparum Sir2: An unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity. Eukaryot. Cell 6:2081-91
126. Hawse WF, Wolberger C. 2009. Structure-based mechanism of ADP-ribosylation by sirtuins. J. Biol. Chem. 284:33654-61
127. Fahie K, Hu P, Swatkoski S, Cotter RJ, Zhang Y, Wolberger C. 2009. Side chain specificity of ADPribosylation by a sirtuin. FEBS J. 276:7159-76
128. Rack JGM, Morra R, Barkauskaite E, Kraehenbuehl R, Ariza A, et al. 2015. Identification of a class of protein ADP-ribosylating sirtuins in microbial pathogens. Mol. Cell 59:309-20
129. Rosenthal F, Feijs KL, Frugier E, Bonalli M, Forst AH, et al. 2013. Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat. Struct. Mol. Biol. 20:502-7
130. Jankevicius G, Hassler M, Golia B, Rybin V, Zacharias M, et al. 2013. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat. Struct. Mol. Biol. 20:508-14
131. Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, et al. 2012. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483:218-21
132. Wagner GR, Payne RM. 2013. Widespread and enzyme-independent N acetylation and N succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 288:29036-45
133. Ghanta S, Grossmann RE, Brenner C. 2013. Mitochondrial protein acetylation as a cell-intrinsic, evolutionary driver of fat storage: chemical and metabolic logic of acetyl-lysine modifications. Crit. Rev. Biochem. Mol. Biol. 48:561-74
134. Jiang W, Wang S, Xiao M, Lin Y, Zhou L, et al. 2011. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 43:33-44
135. Marmorstein R. 2001. Structure and function of histone acetyltransferases. Cell. Mol. Life Sci. 58:693-703
136. Scott I, Webster BR, Li JH, Sack MN. 2012. Identification of a molecular component of the mitochondrial acetyltransferase programme: A novel role for GCN5L1. Biochem. J. 443:655-61
137. Fan J, Shan C, Kang HB, Elf S, Xie J, et al. 2014. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Mol. Cell 53:534-48
138. Shan C, Elf S, Ji Q, Kang HB, Zhou L, et al. 2014. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. Mol. Cell 55:552-65
139. Gibson GE, Xu H, Chen HL, Chen W, Denton TT, Zhang S. 2015. Alpha-ketoglutarate dehydrogenase complex-dependent succinylation of proteins in neurons and neuronal cell lines. J. Neurochem. 134:86-96
140. Hosokawa Y, Shimomura Y, Harris RA, Ozawa T. 1986. Determination of short-chain acyl-coenzyme A esters by high-performance liquid chromatography. Anal. Biochem. 153:45-49
141. King MT, Reiss PD. 1985. Separation and measurement of short-chain coenzyme-A compounds in rat liver by reversed-phase high-performance liquid chromatography. Anal. Biochem. 146:173-79
142. Gao L, ChiouW, Tang H, Cheng X, CampHS, Burns DJ. 2007. Simultaneous quantification of malonyl-CoA and several other short-chain acyl-CoAs in animal tissues by ion-pairing reversed-phaseHPLC/MS. J. Chromatogr. B 853:303-13
143. Cimen H, Han M-J, Yang Y, Tong Q, Koc H, Koc EC. 2010. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49:304-11
144. Finley LWS, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, et al. 2011. Succinate dehydrogenase is a direct target of Sirtuin 3 deacetylase activity. PLOS ONE 6:e23295
145. Huang R, Holbert MA, Tarrant MK, Curtet S, Colquhoun DR, et al. 2010. Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation. J. Am. Chem. Soc. 132:9986-87
146. Li F, Allahverdi A, Yang R, Lua GBJ, Zhang X, et al. 2011. A direct method for site-specific protein acetylation. Angew. Chem. Int. Ed. Engl. 50:9611-14
147. Neumann H, Peak-Chew SY, Chin JW. 2008. Genetically encoding N acetyllysine in recombinant proteins. Nat. Chem. Biol. 4:232-34
148. Lammers M, Neumann H, Chin JW, James LC. 2010. Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization. Nat. Chem. Biol. 6:331-37
149. Huang Y, Russell WK, Wan W, Pai P-J, Russell DH, Liu W. 2010. A convenient method for genetic incorporation of multiple noncanonical amino acids into one protein in Escherichia coli. Mol. BioSyst. 6:683-86
150. Yu W, Dittenhafer-Reed KE, Denu JM. 2012. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J. Biol. Chem. 287:14078-86
151. Gattner MJ, Vrabel M, Carell T. 2013. Synthesis of N-propionyl-, N-butyryl-, and N-crotonyllysine containing histone H3 using the pyrrolysine system. Chem. Commun. 49:379-81